| 2021 |
| |
| 07 |
|
Mass Production of Triple-Injection Synovial Fluid Supplement in the Biotech Plant 1
|
|
|
|
| |
| 2020 |
| |
| 04 |
|
Absorbable Nasal Dressing Launched
|
|
| 05 |
|
Mass Production of Single-Injection Synovial Fluid Supplement in the Biotech Plant 1
HYAJOINT Plus Synovial Fluid Supplement is Approved by Pricing System for Pharmaceuticals (Single Injection per Year) under the Scheme of Taiwan National Health Insurance System
|
|
| 07 |
|
Stablized Synovial Fluid Supplement Launched
|
|
| 09 |
|
HYAJOINT Synovial Fluid Supplement is Approved by TFDA for the New Indication of Shoulder Rotator Cuff Lesions without Complete Tears
|
|
| 11 |
|
Approval of HALAL Assurance System (HAS)
|
|
| 12 |
|
PROTAHERE Absorbable Adhesion Barrier Won the Silver Award in “2020 Research and Development of Pharmaceutical Technology Award”
|
|
|
|
| |
| 2019 |
| |
| 06 |
|
Awarded with the "16th the National Brand YuShan Award" as an Outstanding Enterprise
|
|
| 07 |
|
Sodium Hyaluronate Facial Dermal Implant with Lidocaine in Gel Type Launched
The Biotech Plant 1 is ISO 13485 Certified
|
|
| 08 |
|
The Biotech Plant 1 is GMP Certified for the Class Ⅲ Medical Device by the Ministry of Health and Welfare, Republic of China (Taiwan)
|
|
|
|
| |
| 2018 |
| |
| 08 |
|
DEFEHERE Absorbable Adhesion Barrier Launched in Taiwan
|
|
| 09 |
|
Sodium Hyaluronate Facial Dermal Implant with Lidocaine is CE-MDD 93/42/EEC (ClassIII) Certified and Obtained the CE Marking
|
|
|
|
| |
| 2017 |
| |
| 01 |
|
Sodium Hyaluronate Intravesical Instillation Launched
|
|
| 02 |
|
PROTAHERE Absorbable Adhesion Barrier Launched
|
|
| 03 |
|
European Patent for the Technique of Cross-linked Hyaluronic Acid Platform (CHAP) Granted
|
|
| 06 |
|
Approval of Sedex Members Ethical Trade Audit (SMETA)
|
|
|
|
| |
| 2016 |
| |
| 05 |
|
Sodium Hyaluronate Wound Repair Hydrogel Launched
|
|
| 06 |
|
U.S. Patent for the Technique of Cross-linked Hyaluronic Acid Platform (CHAP) Granted
|
|
| 08 |
|
Signed an Exclusive Distribution Agreement with GALDERMA S.A. (Subsidiary of Nestlé)
|
|
|
|
| |
| 2015 |
| |
| 10 |
|
Approval of Subsidy Project of Investing Development and Promoting Industry from the Kaohsiung City Government
|
|
|
|
| |
| 2014 |
| |
| 04 |
|
Sodium Hyaluronate Facial Dermal Implant Launched in China
Passed the GMP Inspection by Korea Competent Authority
|
|
| 05 |
|
Approval of Canadian Medical Devices Conformity Assessment System (CMDCAS) Certification
|
|
|
|
| |
| 2013 |
| |
| 03 |
|
Taiwan Patent for the Technique of Cross-linked Hyaluronic Acid Platform (CHAP) Granted
|
|
| 11 |
|
Japan Patent for the Technique of Cross-linked Hyaluronic Acid Platform (CHAP) Granted IPOs (Initial Public Offerings) Launched in Taiwan
Sodium Hyaluronate Facial Dermal Implant with Lidocaine Launched
|
|
| 12 |
|
Approval of Taiwan Intellectual Property Management System (TIPS) Certification
|
|
|
|
| |
| 2012 |
| |
| 02 |
|
Single-Injection Synovial Fluid Supplement Launched
|
|
| 10 |
|
Awarded with the “National Industry Innovation Award” from the Ministry of Economic Affairs
Awarded with the “National New Innovation Award” from the Institute for Biotechnology and Medicine Industry
|
|
|
|
| |
| 2011 |
| |
| 05 |
|
Sodium Hyaluronate Hydrogel Wound Dressing Launched
|
|
| 06 |
|
Sodium Hyaluronate Facial Dermal Implant Launched in Korea
|
|
| 12 |
|
China Patent for the Technique of Cross-linked Hyaluronic Acid Platform (CHAP) Granted
|
|
|
|
| |
| 2010 |
| |
| 02 |
|
Sodium Hyaluronate Facial Dermal Implant Launched
Triple-Injection Synovial Fluid Supplement Launched in Philippines
Sodium Hyaluronate Facial Dermal Implant Launched in Italy
|
|
| 12 |
|
Listed on the Taipei Exchange (TPEx) with Emerging Stock Market Code 1786
|
|
|
|
| |
| 2009 |
| |
| 01 |
|
Sodium Hyaluronate Facial Dermal Implant Launched in India
|
|
| 02 |
|
Program for Development of New Leading Products, Facial Dermal Implant of Crosslinked Hyaluronan, was Approved by the Industrial Development Bureau, Ministry of Economic Affairs
|
|
| 05 |
|
Listed as Biotech and New Pharmaceutical Industry by the Industrial Development Bureau, Ministry of Economic Affairs
The ITDP-Fast Track for Clinical Trial Program, Sodium Hyaluronate Facial Dermal Implant Clinical Trial Project, was Approved by the Ministry of Economic Affairs
|
|
| 08 |
|
The Small Business Innovation Research (SBIR), Single-Injection Synovial Fluid Supplement R&D Project, was Approved by the Kaohsiung City Government
|
|
|
|
| |
| 2008 |
| |
| 08 |
|
Triple-Injection Synovial Fluid Supplement Launched
|
|
| 12 |
|
HYAJOINT Synovial Fluid Supplement was Awarded the “National Biomedical Quality Award”
|
|
|
|
| |
| 2006 |
| |
| 01 |
|
The Export Permit for HYADERMIS Facial Dermal Implant was Issued by the Department of Health, Executive Yuan. Registration No. DOH-MD-(E)-No. 000028
The Export Permit for HYAJOINT Synovial Fluid Supplement was Issued by the Department of Health, Executive Yuan. Registration No. DOH-MD-(E)-No. 000029
|
|
| 08 |
|
Triple-Injection Synovial Fluid Supplement Launched in India
|
|
|
|
| |
| 2005 |
| |
| 01 |
|
Achieved the ISO 9001 and ISO 13485 Certification for Medical Device Quality Management System
|
|
| 03 |
|
Sodium Hyaluronate Facial Dermal Implant was CE-MDD 93/42/EEC (Class III) Certified and Obtained the CE Marking
|
|
| 07 |
|
Awarded with the “Product Innovation Leadership Award of the Biomedical Material Category” from the Frost & Sullivan Awards.
|
|
| 09 |
|
The Medical Device Plant was GMP Certified for the Class Ⅲ Medical Device by the Department of Health, Executive Yuan
|
|
| 12 |
|
Sodium Hyaluronate Synovial Fluid Supplement was CE-MDD 93/42/EEC (Class III) Certified and Obtained the CE Marking
Awarded with the “Export Processing Zone Innovative Research and Development Award” from the Ministry of Economic Affairs
|
|
|
|
| |
| 2004 |
| |
| 09 |
|
Awarded with the “Investment Incentive Program” from the Kaohsiung City Government
|
|
|
|
| |
| 2003 |
| |
| 03 |
|
Achieved the CNLA Certification (The First Certified Parentage Testing Laboratory in Taiwan).
|
|
| 12 |
|
Program for Development of New Leading Products, Medical Grade Hyaluronic Acid, was Approved by the Ministry of Economic Affairs
|
|
|
|
| |
| 2002 |
| |
| 10 |
|
Achieved the ISO 9001 Certification
|
|
|
|
| |
